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The inositol 1,4,5-trisphosphate (IPa)-sensitive Ca2+ compartment of endocrine cells was studied with ex-
toxin- and digitonin-permeabilized rat insulinoma (RINA2) and rat pheochromocytoma (PCI2) cells. The 
Ca2+ uptake was ATP-dependent, and submicromolar concentrations ofIPa specifically released the stored 
Ca2+. Half-maximal Ca2+ release was 'observed with 0.25--O.5,umol of IPa/l, and the amount of Ca2+ 
released due to IPa could be enhanced by additional loading of the Ca2+ compartment. Consecutive 
additions of the same concentration of IPa for 1-2 h always released the same amount of Ca2+ without 
desensitization, providing an ideal basis to further characterize the IPa-induced Ca2+ release. Here we 
describe for the first time a reversible inhibitory effect of decavanadate on the IPa-induced Ca2+ release. 
Among the vanadium species tested (decavanadate, oligovanadate and monovanadate), only decavanadate 
was inhibitory, with a half-maximal effect at 5 ,umoljl in both cell types. The effect of decavanadate could 
be overcome by increasing the amount of sequestered Ca2+ or added IPa. Decavanadate did not affect the 
ATP-driven Ca2+ uptake but oligovanadate was inhibitory on Ca2+ uptake. p-Hydroxymercuribenzoate 
(pHMB) at concentrations between 10 and 30,umoljl also inhibited the Ca2+ release due to IPa. Thiol 
compounds such as dithiothreitol (DTT; 1 mmoljl) added before pHMB removed all its inhibitory effect on 
the IPa-induced Ca2+ release, whereas the inhibition caused by decavanadate was unaffected by DTT. Thus, 
the decavanadate-dependent inhibition functions bya distinctly different mechanism than pHMB and could 
serve as a specific tool to analyse various aspects of the IPa-induced Ca2+ release within endocrine cells. 
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Materials 
83 
The receptor-stimulated hydrolysis of inositol 
phospholipids and the mobilization ofintracellular Ca2+ 
stores is a common mechanism for transmembrane 
signalling when cells respond to external stimuli as diverse 
as hormones, neurotransmitters and antigens (cf. Ber-
ridge, 1987). Rises in the intracellular free Ca2+ con-
centration are key events in a variety of cellular processes 
including the control of exocytosis. The intracellular free 
Ca2+ concentration is regulated by Ca2+ transport systems 
present in the plasma membrane as weil as intracellular 
sequestering systems such as mitochondria, secretory 
vesicles and the endoplasmic reticulum. The latter is 
characterized by the ability to sequester Ca 2+ in an A TP-
dependent manner and to release it upon stimulation 
with micromolar concentrations of inositol 1,4,5-tris-
phosphate (IP a)' A common problem encountered when 
working with this IPa-sensitive Ca2+ compartment is the 
desensitization of the Ca2+ release upon repeated ap-
plication of a given concentration of IP a (Rossier et al., 
1987). In the present work it is demonstrated that 
appropriately permeabilized cells respond to IP a for 
periods longer than 1 h without desensitization. With 
such cellular preparations, a careful analysis of the IP a-
induced Ca2+ release and its characterization with specific 
reagents is possible. 
Defined species ofvanadate were prepared as described 
below using ortho- and metavanadate from Sigma (St. 
Louis, MO, U.SA.). The pore-forming pro tein ex-toxin 
from Staphylococcus aureus was purified as described by 
Lind et al. (1987). Inositoll ,4-bisphosphate (IP 2) and IP 3 
were from Boehringer (Mannheim, Germany). Inositol 
1,3,4,5-tetrakisphosphate was kindly given by Dr. R. F. 
Irvine (Cambridge, U.K.). Ca2+-selective membranes 
containing the neutral carrier ETH 129 were kindly 
provided by W. Simon (ETH, Zürich, Switzerland). The 
firefty assay for determination of ATP was obtained from 
Boehringer. KCl (suprapure) was from Merck (Darm-
stadt, Germany) and Azur A was from Fluka (Neu-Ulm, 
Germany). All other chemicals were analytical grade. 
Cell culture and preparation for Ca2+ measurement 
Rat insulinoma (RINA2) and pheochromocytoma 
(PCI2) cells were cultured in 60 mm wells containing 
3 ml of RPMI 1640 medium supplemented with 10% 
(v Iv) fetal calf serum in an atmosphere of 10 % CO2 
as described previously (Ahnert-Hilger et al., 1985; 
Lind et al., 1987). Before permeabilization, the cells were 
washed 3 times with medium A containing KCl 
Abbreviations used: IP 3' inositol I ,4,5-trisphosphate; IP 2 inositol I ,4-bisphosphate; IP 4' inositol I ,3,4,5-tetrakisphosphate; pHMB, p-hydroxy-
mercuribenzoate; DIT, dithiothreitol; h.u., haemolytic units. 
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(150 mmolfl), NaN3 (5 mmol/l), Mops (20 mmol/l), 
pH 7.2, and EGTA (I mmol/I). For permeabilization 
with (X-toxin, the cells were suspended in medium A and 
incubated with 300 haemolytic units (h.u.) of (X-toxin/ 
107 cells for 10 min on ice followed by 30 min at 30 oe. 
Digitonin permeabilization was carried out in the cold 
directly in the culture wells (25 pmol of digitonin/l 
in medium A containing 0.1 % dimethyl sulphoxide; 
10 min) (Ahnert-Hilger et al., 1989b). Permeabilization 
was controlled by counting the Azur A-stained cells 
[0.25 % Azur A in NaCI (ISO mmolfl)/NaN3 (5 mmolfl)1 
Mops (20 mmol/l), pH 7.2] in a Neubauer ~hamber. 
Following permeabilization, the cells were washed three 
times with medium B (medium A without EGT A) before 
the Ca2+ measurements. 
Measurement of the ambient free Ca2+ concentration 
Ca 2+ -specific mini-electrodes were prepared as de-
scribed by Simon et al. (1978) and were calibrated before 
and after each experiment. The poly(vinyl chloride) 
membrane of the electrode contained the recently de-
veloped neutral carrier ETH 129, which allows reliable 
measurements of Ca2+ down to the nanomolar range 
(Ammann et al., 1987). All chemicals used in the experi-
ments were tested for Ca2+ contamination and· Ca2+-
binding activity in medium B. At experimental con-
centrations no electrode interference was detected. 
Experiments were carried out at room temperature 
and pH 7.2 in 300-500 pi of medium B containing 
(25-10) x 106 cells. 
Other methods 
Pro tein was measured according to Smith et al. (1985) 
using bovine serum albumin as standard. For deter-
mination of cell volume, the mean cell diameter was 
estimated under a microscope and the volume calculated 
under the assumption of a spherical cell form. A TP was 
determined using the firefty assay as described elsewhere 
(Lind et al., 1987). 
Characterization and preparation of vanadate solutions 
The speciation of vanadate· in aqueous solution is 
strongly dependent on both the pH and the absolute 
vanadate concentration as analysed with 51V n.m.r. 
spectroscopy. At pH 7.2, vanadate (total 1.25 mmol/l) 
exists as 50 % tetramer, 30 % monomer, 10% dimer and 
10% other species. At pH 3.75, vanadate exists solely as 
decavanadate (Pettersson et al., 1983). 
Concentrated stock solutions of vanadate were pre-
pared by dissolving crystals of either ortho- or meta-
vanadate as purchased from the supplier in I mol of 
KOH/I (monovanadate). All other vanadate solutions 
used were prepared freshly from this stock solution. 
Decavanadate was prepared by dilution of the stock 
solution with KCI (ISO mmolfl)/Mops (20 mmol/l) 
pH 7.2, and titration to pH 3.75 with concentrated HCI. 
Solutions were subsequently diluted to 5 mmolfl and 
stored at 4 °C until use. Solutions prepared in this manner 
were effective even after several months (results not 
shown). 
Decavanadate is the thermodynamically stable species 
at pH 3.75. Its yellow colour is due to a broad shoulder 
around 350--400 nm. Upon adjustment of the decavan-
adate solution from pH 3.75 to pH 7.2, decavanadate 
decomposes slowly to oligomeric forms. We found at 
experimental conditions (room temperature and pH 7.2) 
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a half-life of decavanadate (200 pmolfl) in medium B of 
approx. 2 h, thus allowing ample time for completion of 
all experiments without significant inftuence of oligomeric 
vandate species. 
Oligovanadate solutions were prepared by titration of 
stock solutions to pH 7.2 with conc. HCI. The yellow 
colour formed during titration is due to decavanadate 
as identified by spectroscopy and disappeared upon 
boiling. After cooling to room temperature, the pH was 
checked again. This procedure was repeated until a 
colourless solution of pH 7.2 was obtained containing 
oligovanadate and monovandate. The solution was then 
diluted to a final concentration of 50 mmol/I and stored 
at room temperature. In this manner, stable oligovan-
adate solutions free of decavanadate can be prepared. 
RESULTS 
Characterization of the ATP and IP 3-sensitive Ca2+ 
pool in permeabilized PCl2 and RINA2 cells 
Cell poration by (X-toxin is restricted to the plasma 
membrane and allows the passage of low-molecular-
mass substances (Ahnert-Hilger et al., 1985, 1989b; 
Bhakdi & Traunum-Jensen, 1987). By contrast, per-
meabilization with digitonin in addition allows the 
diffusion of higher molecular mass proteins. Since no 
difference in the ATP-dependent Ca2+ uptake or IP3-
induced Ca2+ release was found using either method of 
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Fig. 1. Ca2+ uptake and ATP hydrolysis by digitonin-per-
meabilized RINA2 cells incubated with low cODCentratioDS 
ofATP 
Cells (4.2 x 108 ) were incubated at room temperature in 
medium B (150 mmol of KCI/I/20 mmol of Mops/I, 
pH 7.2/5 mmol of NaNa/l) containing I mmol of Mg2+ /1. 
Arrows indicate the addition of cells, permeabilized with 
25 pmol of digitonin/I, and ATP. For determination of 
ATP, 20 pi aliquots were removed and diluted in 10 vol. of 
preheated buffer (assay buffer for ATP determination) and 
boiled for 5 min. After cooling, the denatured cellswere 
centrifuged for 2 min at 10000 g. Tbe supernatant was 
analysed by means of the firefly assay for ATP. Con-
centrations of ATP stock solutions were controlled spectro-
photometrically at 259 nm with the molar absorption 
coefficient given by Mahoney et al. (1986). 
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Fig. 2. Eft'ect of decavanadate aad oUgovanadate on A TP-
dependent Ca2+ uptake . 
Ca2+ uptake at different oligovanadate (e) or decavan-
adate (0) concentrations was determined with 5 ,umol of 
A TP /1 as shown in Fig. I. 100 % Ca 2+ uptake corresponds 
to the sequestration of 1.25 nmol of Ca2+ by 107 cells. 
Vanadate concentrations are referred to the monomeric 
form. 
Table 1. ATP-dependent Ca2+ uptake and IPa (5 pmol,l)-
iaduced Ca2+ release from RINAl and PCll cells 
Results are expressed as means ± S.D. of three independent 
experiments. 
Ca2+ uptake Ca 2+ release 
(nmol/mg (nmol/mg Release 
Cells of protein) of protein) (% of uptake) 
RINA2 1O.6±2.7 7.1±1.7 66.9±7.7 
PCI2 5.8± 1.3 4.0±O.9 68.9±22.2 
permeabilization, an involvement of soluble cytoplasmic 
proteins in both processes is unlikely. 
ATP-dependent Ca2+ uptake and its inhibition by 
oligovanadate 
Intact PCI2 and RINA2 cells suspended in a buffered 
KCl medium (medium B) containing 5 mmol of NaNa/l 
and 1-2 Jlmol of free Ca2+ /1 exhibited no Ca:2+ uptake. 
Permeabilized cells sequestered Ca 2+ provided that A TP 
was present. Small amounts of ATP (10-20 Jlmol/l) 
resulted in a transient Ca2+ storage in the permeabilized 
cells (Fig. I). The stored Ca2+ was released again upon 
the A TP concentration dropping below 1 Jlmolfl (Fig. 
1). Under these conditions, the cells required 100-
200 Jlmol of A TP /1 to maintain steady-state Ca 2+ levels of 
approx. 0.2-0.4 Jlmol/l. Most experiments were routinely 
carried out in the presence of 2 mmol of Mg-A TP /1 to 
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Table 2. Correlation of ceU Dlunber to ceU volume and ceU 
protein 
Values represent the means±s.D. ofnumbers ofmeasure-
ments given in parentheses. 
Cells 
RINA2 
PCl2 
Cell volume 
(,ul/W cells) 
16.1 ±2.4 (n = 100) 
14.9±2.6 (n = 100) 
Protein 
(mg/W cells) 
1.51 ±O.09 (n = 9) 
1.1 ±O.3 (n = 4) 
ensure an excess of ATP for longer incubations (up to 
4 h). Ca 2+ uptake determined as shown in Fig. I was 
not inftuenced by decavandate, but oligovanadate was 
strongly inhibitory (Fig. 2). This finding allowed us to 
analyse the effect of different vanadate species on the IP a-
induced Ca2+ release. 
Release of stored Ca2+ by IP a 
Submicromolar concentrations of IP a caused the re-
lease of Ca2+ (Figs. 3a and 3b). This release was highly 
specific for IP a, since IP" IP 2 and inositol were ineffective 
(results not shown). For both RINA2 and PCI2 cells, the 
minimal releasing concentration was at 0.01 Jlmol of 
IP a/1. Half-maximal release was obtained between 0.25 
and 0.5 Jlmol ofIPa/l (Figs. 3a and 3b). An immediate re-
uptake of Ca2+ followed each release. The level of Ca2+ 
reached in the presence of 2 mmol of Mg2+ -A TP /1 with 
permeabilized rat insulinoma or pheochromocytoma cells 
was around 0.1 Jlmol of free Ca2+ /1. IP a was commonly 
added when the cells reached an ambient free Ca2+ 
concentration of approx. 0.2-0.4 Jlmol of Ca2+ /1 (Figs. 
3a and 3b). Maximal IPa concentrations (1-5 Jlmol/l) 
resulted in a rise of ambient free Ca2+ to around 0.6-
0.8 Jlmolfl (Figs. 3a and 3b), corresponding to arelease 
of 60-80 % of the sequestered Ca 2+ (Table I). From these 
data, it can be calculated that RINA2 and PCI2 cells in 
the presence of 2 mmol of Mg-A TP /1 sequester approx. 
1O.6±2.7 and 5.8± 1.3 nmol of Ca2+/mg of protein 
respectively (Table 1). 
Since I mg of cell pro tein corresponds to a cell volume 
of approx. 10-13 Jll (Table 2), the IPa-sensitive Ca2+ 
storage system could give rise to intracellular Ca 2+ 
concentrations up to or higher than 100 Jlmolf1. Pro-
longed incubation did not change the ability to store 
Ca2+ as well as to release it upon a given IP a con-
centration, indicating that no desensitization occurred 
(Fig. 4a). Furthermore, the IP a-induced Ca2+ release 
directly depended upon the amount of sequestered Ca2+ 
(Figs. 4a and 4b). Sequential additions of small amounts 
of Ca2+ after the initial Ca2+ uptake increased the Ca2+ 
release when stimulated with an equal IP 3 concentration 
(Fig. 4b), indicating that the amplification of the IPa 
signal in secretory cells depends on the 'charge' of the 
Ca2+ battery. From Fig. 4(a), it was calculated that one 
molecule of IPa could release up to 30 Ca'-!- ions. 
Inhibition of the IPa-induced Ca2+ release 
Decavanadate and pHMB inhibited the IP a-induced 
Ca2+ release in both RINA2 and PCl2 cellS. Deca-
vanadate (5 Jlmol/l) resulted in an almost half-maximal 
inhibition of Ca2+ release induced by 0.25 Jlmol of 
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Fig. 3. Ca2+ release induced by different concentrations of IP3 from «-toxin-permeabilized RINA2 (a) aod Pel2 (b) cells 
Cells were incubated in medium B containing 2 mmol of Mg2+ /1 and 2 mmol of ATP /1. The arrows indicate the addition of 
increasing amounts of IP3 (between 0.05 and 2.0 nmol) corresponding to final concentrations of between 0.125 and 5pmol/1. 
The calibration ofthe Ca2+ release was carried out by sequential addition ofa Ca2+ standard. The absolute Ca2+ release/107 cells 
as calculated from these data is shown in the inserts of this Figure. 
IPa/1 (Fig. 5a). Further addition of decavanadate (10-
15-,umoljl) inhibited the release by up to 90 % (Fig. 5a). 
At higher concentrations, decavanadate released Ca2+ 
(results not shown). The effect of decavanadate was 
found to be reversible (Fig. 5b) and could be overcome 
by increasing the amount either ofsequestered Ca2+ or of 
added IP a (Fig. 5c). Neither oligovanadate (Fig. 5d) nor 
the closely related arsenate (results not shown) were 
inhibitory on the IPa-induced Ca2+ release. Low concen-
trations of the thiol-reactive reagent pHMB exhibited 
similar effects. The effective concentrations for inhibition 
of IPa-induced Ca2+ release by pHMB were observed at 
about 10-30,urnol/l (Fig. 6a). Again, higher concen-
trations resulted in a total release of sequestered Ca2+ 
(result not shown). The pHMB effect could be abolished 
by an excess ofthiol compounds such as DTT (1 mmol/l) 
(Fig. 6b). By contrast, the addition ofDTT had no effect 
on the decavanadate-induced inhibition (results not 
shown). Nitro-group-containing compounds such as 
nitroprusside or nitroglycerin, which were reported to 
interfere with the mobilization of intracellular Ca2+ in 
smooth muscle (cf. Shibata .etal~,.1987). were not 
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Fig. 4. Ca2+ release by tbe same amoUDt ofIPa from «-toxin-permeabilized RINAl ceUs is constant (a) but can be increased byadditional 
loading with Ca2+ (b) 
Arrows indicate tbe addition ofIPa and Ca2+. Note tbe increased IPa-induced Ca2+ release after sequential additions of I nmol 
ofCa2+. 
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Fig. S. Eifert of decavanadate (0, b, c) and oligovanadate (d) on IPa-induced Ca2+ release in digitonin-permeabilized RINA2 cells 
(a) Inbibition of tbe IPa-induced Ca2+ release by increasing concentrations of decavanadate. Tbe values are expressed as tbe 
percentage of Ca2+ released from permeabilized RINA2 cells as compared witb tbe release elicited by 0.25 .umol of IP all (100 % ; 
n = 3; means±s.D.). (b) Tbe inhibitory effect of decavanadateon tbe IPa-induced Ca2+ release is reversible. Permeabilized cells 
were treated with 15.umol of decavanadate/l (batcbed bars) or an equivalent amount of medium B (open bars). Following 
centrifugation (400 g, 2 min) tbe amount of Ca2+ released by 0.25 .umol of IP all (100 %; n = 4) in tbe presence or absence of 
15 pmol of decavanadate/l was determined in tbe resuspended cells. (c) Tbe inbibition of tbe IPa-induced Ca2+ release by 
decavanadate can be overcome by increasing tbe amount of stored Ca2+. Experimental conditions were tbe same as in (a). 
Arrows indicate tbe addition of IPa (final concentrations 0.1 and 0.25 pmol/l). Tbe arrowbead indicates tbe addition of 
decavanadate (final concentration 5 pmoljl). Tbe inbibition by decavanadate is overcome by additionalloading of Ca 2+ into tbe 
compartment. (d) Tbe inftuence of oligovanadate on tbe IPa-induced Ca2+ release. Experimental conditions were as in (c). Eacb 
arrow indicates the addition ofO.1 nmol ofIPs (corresponding to 0.25 pmoljl). Eacb arrowbead indicates tbe addition of 4 nmol 
of oligovanadate (corresponding 10 10 pmol/l). 
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Fig. 6. The inhibition of the IP a-induced Ca2+ release in digitonin-
permeabilized RINA2 ceUs by pHMB (a) is abolished by 
DTT (b) 
Experimental conditions were the same as in Fig. Sc. Each 
arrow indicates the addition of 0.1 nmol of IPa (cor-
responding to 0.25 pmolj 1); each arrowhead indicates the 
addition of 4 nmol ofpHMB (corresponding to 10 pmoljl). 
effective in inhibiting the IPa-induced Ca2+ release (results 
not shown). 
DISCUSSION 
The regulation of cytosolic free Ca2+ is accomplished 
by several cellular Ca2+ transport systems, comprising 
the plasma membrane, mitochondria and endoplasmic 
reticulum. Mobilization of Ca2+ by IPa from the latter is 
part of an intracellular signal-transducing system com-
mon to many different cell types. Experimental conditions 
excluded the plasma membrane by permeabilization and 
the mitochondria by addition of NaNa. Thus the free 
Ca2+ concentration was mainly regulated by the endo-
plasmic reticulum or the so-called IPa-sensitive Ca2+ 
compartment (Streb et al., 1983; Berridge, 1987). 
As shown here, pHMB inhibits the IPa-induced Ca2+ 
release in rat insulinoma and rat pheochromocytoma 
cells. This finding correlates weil with the situation seen 
in platelets (Adunyah & Dean, 1986) and the inhibition of 
the binding ofIPa to its receptor in brain cell preparations 
by an analogue of pHMB, p-chloromercurisulphonate 
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(Supattapone et al., 1988). Thus the inhibition of the IP 3-
induced Ca2+ release by pHMB is probably the result of 
decreased binding of IPa to its receptor protein. Supat-
tapone et al. (1988) also found, as reported here for the 
IPa-induced Ca2+ release, that this inhibition could be 
prevented by the addition of DTT. 
Decavanadate similarly inhibits the IPa-induced Ca2+ 
release. However, although almost equally potent, the 
mechanisms of inhibition by decavanadate and pHMB 
appear to be different. The inhibition by decavanadate is 
unaffected by the addition of DTT, indicating that 
decavanadate does not act by oxidation of essential 
thiol groups of the IP a receptor protein. However, the 
observed inhibition of the IPa-induced Ca2+ release by 
low concentrations of decavanadate suggests a specific 
interaction of decavanadate with the IP 3 receptor protein. 
As stated above, vanadate exists in several forms, each 
of which influences a different component of the intra-
cellular Ca2+ uptake and release systems. As observed 
in this study, deeavanadate specifically inhibits the IP a-
induced Ca2+ release. On the other hand oligo- and 
monovanadate inhibit the ATP-dependent Ca2+ uptake 
by permeabilized endocrine cells (Prentki et al., 1984). 
This blockade is most probably due to the binding ofthe 
various oligomeric vanadate species to the Ca2+ transport 
ATPase (cf. Csermely et al., 1983; Varga et al., 1985). 
Indeed, we observed here that oligovanadate but not 
decavanadate inhibits A TP-driven Ca 2+ uptake. 
Permeabilized cell preparations have been instrumental 
in the investigation of intracellular Ca 2+ transport 
(Prentki et al., 1984), the effects of IP a on intracellular 
Ca2+ compartments (Streb et al., 1983; Berridge, 1987), 
IP a binding to its intracellular receptor (Spät et al., 1986) 
and in the analysis of the intracellular requirements for 
exocytosis (Knight & Baker, 1982; Ahnert-Hilger et al., 
1985, 1987; Bader et al., 1986). The present investigation 
enlarges data on Ca2+ metabolism in endocrine tumour 
celllines and shows for the first time the inhibition of the 
IPa-induced Ca2+ release by decavanadate and pHMB in 
these cell types. Inhibition ofthe IPa-induced Ca2+ release 
by decavanadate was reversible and could be overcome 
by increasing either the amount of sequestered Ca2+ or 
the IP 3 concentration used. 
The IPa-induced Ca2+ release from permeabilized 
RINA2 cells was, when analysed in the presence of milli-
molar concentrations of A TP, similar in quality and 
quantity to data described earlier (Biden et al., 1984). 
The properties of PC12 cells may be compared with 
those of chromaffin cells in primary culture (Stöhr et al., 
1986; Kao, 1988). Chromaffin cells exhibited an IPa-
induced Ca2+ release ofapprox. 20 % ofthat ofPCI2 cells 
(Stöhr et al., 1986) or even less (Kao, 1988), which led to 
the conclusion that Ca2+ release induced by IPa may play 
only a small role in the physiological stimulation by 
acetylcholine. Furthermore, upon repeated addition of 
IPa, a 'complete desensitization' occurred in these cells, 
i.e. a second addition of IP a failed to elicit further Ca2+ 
release (Stöhr et al., 1986). Therefore, long-term investi-
gations as described here for PC12 cells cannot be carried 
out with such chromaffin cell preparations. 
The endocrine cells used in this study have been 
permeabilized in two different ways. The stable pores 
provided by ex-toxin (Füssle et al., 1981; Bhakdi & 
Traunum-Jensen, 1987) are an almost ideal tool for the 
investigation of the role of sm all molecules (up to 1 kDa) 
on intracellular Ca2+ metabolism. On the other hand, the 
1989 
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use of digitonin and other pore-forming proteins like 
streptolysin 0 allows the extraction of large molecules 
from permeabilized cells (Dunn & Holz, 1983; Wilson & 
Kirshner, 1983; Ahnert-Hilger et al., 1985) and the 
introduction of others (Ahnert-Hilger et al., 1989a,b). 
Since, as reported here, Ca 2+ uptake and release can be 
measured for long periods of time (even longer than 2 h) 
using both protocols for permeabilization, the membrane 
structure which accumulates Ca2+ with the aid of ATP 
and releases it upon addition of IP a can now be in-
vestigated with a variety of different substances. A closer 
definition of the endoplasmic reticulum or other related 
structures (Volpe et al., 1988) engaged in intracellu1ar 
Ca 2+ regulation is now feasible; Specific inhibitors of IP a 
function, such as decavanadate described here, could 
then be used as valuable tools to further analyse the 
mechanism of the IPa-induced Ca2+ release in cellular 
signal transduction. 
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